Clovis Oncology Collaborates With GSK To Assess New Drug Combination In Non-Small Cell Lung Cancer
News
Clovis Oncology, Inc. is collaborating with GlaxoSmithKline LLC to design a clinical trial that aims to evaluate a new combination therapy targeting mutant epidermal growth factor receptor (EGFR) in non-small cell lung cancer (NSCLC). This phase ... Read more